Race har ingen klinisk relevant effekt på laropiprants farmakokinetik på basis af en sammensat analyse af farmakokinetiske data, herunder hvide, latinamerikanere, negroide, asiater og indianere.
Race had no clinically meaningful effect on the pharmacokinetics of laropiprant based on a composite analysis of pharmacokinetic data including subjects of White, Hispanic, Black, Asian, and Native American racial groups.